Response criteria for glioma
A Gregory Sorensen*, Tracy T Batchelor, Patrick Y Wen, Wei-Ting Zhang and Rakesh K Jain
Correspondence *Mailcode 149-2301, Building 149, 13th Street, Boston, MA 02129, USA
Email sorensen@nmr.mgh.harvard.edu
The current method for assessing response to therapy of glial tumors is based on the Macdonald et al. criteria; however, these criteria are ambiguous in key features such as the appropriate threshold for lesion size and the actual methods for applying the stated criteria. The authors of this Review identify the strengths and shortcomings of the current approach and also discuss technological advances in both drug therapy and imaging that necessitate reassessment of the Macdonald et al. criteria.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.